title: Immunity to oncogenic proteins.
authors.affiliation: Department of Medicine, University of Washington, Seattle 98195, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Cheever
authors.forename: M L
authors.initials: ML
authors.lastname: Disis
authors.forename: H
authors.initials: H
authors.lastname: Bernhard
authors.forename: J R
authors.initials: JR
authors.lastname: Gralow
authors.forename: S L
authors.initials: SL
authors.lastname: Hand
authors.forename: E S
authors.initials: ES
authors.lastname: Huseby
authors.forename: H L
authors.initials: HL
authors.lastname: Qin
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: W
authors.initials: W
authors.lastname: Chen
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D016044:Fusion Proteins, bcr-abl / Q000276:immunology; D006801:Humans; D015689:Oncogene Protein p21(ras) / Q000276:immunology; D010446:Peptide Fragments / Q000276:immunology; D011518:Proto-Oncogene Proteins / Q000276:immunology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D016044:Fusion Proteins, bcr-abl; D015689:Oncogene Protein p21(ras); D010446:Peptide Fragments; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; C091577:HER2-neu-derived peptide (654-662)